Quick Takeaways
- Stonepine Capital Management, LLC filed SCHEDULE 13G for Inovio Pharmaceuticals, Inc. Common Stock (INO).
- Disclosed ownership: 5.2%.
- Date of event: 17 Dec 2024.
Stonepine Capital Management, LLC - 17 Dec 2024 SCHEDULE 13G Report for Inovio Pharmaceuticals, Inc. Common Stock (INO)
- Filing Manager
- Stonepine Capital Management, LLC
- Reporting Manager
- Stonepine Capital Management, LLC
- Symbol
- INO
- Shares outstanding
- 36,858,962 shares
- Disclosed Ownership
- 1,916,666 shares
- Ownership
- 5.2%
- Form type
- SCHEDULE 13G
- Filing time
- 23 Dec 2024, 20:08:57 UTC
- Date of event
- 17 Dec 2024
- Next filing
- 14 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Stonepine Capital Management, LLC disclosed 5.2% ownership in Inovio Pharmaceuticals, Inc. Common Stock (INO) on 17 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 23 Dec 2024, 20:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC | 5.2% | 1,916,666 | 0 | 1,916,666 | /s/ Jon M Plexico | Managing Member | |
| Stonepine Capital, L.P. | 5.2% | 1,916,666 | 0 | 1,916,666 | /s/ Jon M. Plexico | Managing Member of the General Partner, Stonepine GP, LLC | |
| Stonepine GP, LLC | 5.2% | 1,916,666 | 0 | 1,916,666 | /s/ Jon M. Plexico | Managing Member | |
| Jon M. Plexico | 5.2% | 1,916,666 | 0 | 1,916,666 | /s/ Jon M. Plexico | Reporting person |